Egyptian Journal of Medical Human Genetics

Table 2 Frequency of immunophenotyping, hMICL, and WT1 genotyping in AML cases

From: The prognostic impact of Wilms tumor-1 polymorphism (rs16754) and human myeloid inhibitory C-type lectin-like receptor expression in cytogenetically normal-acute myeloid leukemia

Parameters	AML cases (N = 63)
Parameters	Positive cases (%)	Negative cases (%)	Mean ± SD
CD33	58 (92.1)	5 (7.9)	54.54 ± 23.07
CD13	54 (85.7)	9 (14.3)	53.56 ± 25.85
CD14	7 (11.1)	56 (88.9)	18.00 ± 13.42
CD117	44 (69.8)	19 (30.2)	38.83 ± 24.85
MPO	53 (84.1)	10 (15.9)	51.00 ± 26.01
CD34	37 (58.7)	26 (41.3)	34.51 ± 27.79
HLA-Dr	63 (100)	0 (0)	40.40 ± 24.28
HMICL	55 (87.3)	8 (12.7)	64.41 ± 29.67
WT1 genotypes
AA	46 (73.0)
AG	15 (23.8)
GG	2 (3.2)

Back to article page